Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 9 | 2021 | 706 | 2.450 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 8 | 2013 | 57 | 2.240 |
Why?
|
| Dengue | 9 | 2024 | 94 | 2.010 |
Why?
|
| Simian immunodeficiency virus | 8 | 2013 | 59 | 1.970 |
Why?
|
| Morphine Dependence | 6 | 2010 | 25 | 1.770 |
Why?
|
| Puerto Rico | 23 | 2024 | 1378 | 1.350 |
Why?
|
| Aedes | 3 | 2023 | 34 | 1.250 |
Why?
|
| Dengue Virus | 4 | 2023 | 85 | 1.250 |
Why?
|
| HIV Infections | 6 | 2021 | 2303 | 1.170 |
Why?
|
| Drug Resistance, Viral | 4 | 2021 | 63 | 1.150 |
Why?
|
| Arboviruses | 2 | 2023 | 5 | 1.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2021 | 215 | 1.010 |
Why?
|
| Viral Envelope Proteins | 2 | 2019 | 82 | 0.960 |
Why?
|
| Chikungunya virus | 3 | 2023 | 16 | 0.950 |
Why?
|
| Genotype | 5 | 2020 | 730 | 0.860 |
Why?
|
| Sequence Analysis, DNA | 5 | 2020 | 474 | 0.840 |
Why?
|
| Morphine | 3 | 2013 | 85 | 0.780 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2021 | 7 | 0.780 |
Why?
|
| Disease Progression | 6 | 2013 | 601 | 0.780 |
Why?
|
| Saliva | 2 | 2020 | 107 | 0.770 |
Why?
|
| Humans | 42 | 2024 | 37093 | 0.690 |
Why?
|
| Executive Function | 1 | 2020 | 49 | 0.680 |
Why?
|
| Gene Products, env | 2 | 2009 | 23 | 0.640 |
Why?
|
| Mutation | 7 | 2023 | 1095 | 0.630 |
Why?
|
| Evolution, Molecular | 4 | 2015 | 268 | 0.560 |
Why?
|
| Campylobacter jejuni | 6 | 2004 | 22 | 0.550 |
Why?
|
| Mental Disorders | 1 | 2020 | 309 | 0.540 |
Why?
|
| Bacteria | 1 | 2018 | 255 | 0.520 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 519 | 0.510 |
Why?
|
| Inflammation | 1 | 2020 | 618 | 0.510 |
Why?
|
| Adult | 17 | 2024 | 11712 | 0.500 |
Why?
|
| Antigens, Bacterial | 5 | 2004 | 132 | 0.470 |
Why?
|
| Gene Products, vpr | 1 | 2013 | 5 | 0.460 |
Why?
|
| Dengue Vaccines | 2 | 2023 | 13 | 0.450 |
Why?
|
| Animals | 19 | 2023 | 15081 | 0.450 |
Why?
|
| AIDS Dementia Complex | 1 | 2014 | 102 | 0.450 |
Why?
|
| Antibodies, Viral | 4 | 2023 | 262 | 0.450 |
Why?
|
| Depression | 1 | 2020 | 712 | 0.450 |
Why?
|
| Glutamic Acid | 1 | 2014 | 128 | 0.450 |
Why?
|
| Mutation, Missense | 1 | 2013 | 83 | 0.440 |
Why?
|
| Arbovirus Infections | 2 | 2023 | 5 | 0.430 |
Why?
|
| Virulence Factors | 1 | 2013 | 113 | 0.420 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2024 | 103 | 0.410 |
Why?
|
| Phylogeny | 4 | 2023 | 644 | 0.410 |
Why?
|
| Male | 18 | 2024 | 20025 | 0.400 |
Why?
|
| Immunoglobulin M | 2 | 2022 | 82 | 0.400 |
Why?
|
| Brain | 2 | 2009 | 1346 | 0.400 |
Why?
|
| Opioid-Related Disorders | 2 | 2013 | 125 | 0.400 |
Why?
|
| Influenza, Human | 2 | 2022 | 83 | 0.390 |
Why?
|
| Fever | 2 | 2022 | 57 | 0.380 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 14 | 0.370 |
Why?
|
| Interleukin-18 | 1 | 2010 | 15 | 0.370 |
Why?
|
| Genetic Variation | 5 | 2020 | 387 | 0.370 |
Why?
|
| Child | 10 | 2024 | 3131 | 0.370 |
Why?
|
| Interleukin-12 | 1 | 2010 | 47 | 0.370 |
Why?
|
| Macaca | 5 | 2009 | 38 | 0.360 |
Why?
|
| Young Adult | 10 | 2024 | 4268 | 0.360 |
Why?
|
| Female | 16 | 2024 | 20969 | 0.350 |
Why?
|
| Retroviridae Proteins | 1 | 2009 | 7 | 0.340 |
Why?
|
| Cohort Studies | 5 | 2023 | 1492 | 0.310 |
Why?
|
| Middle Aged | 10 | 2024 | 10129 | 0.310 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 2721 | 0.310 |
Why?
|
| Reassortant Viruses | 1 | 2006 | 10 | 0.290 |
Why?
|
| Macaca mulatta | 3 | 2013 | 128 | 0.270 |
Why?
|
| Sensitivity and Specificity | 2 | 2024 | 562 | 0.260 |
Why?
|
| Mosquito Control | 2 | 2023 | 14 | 0.260 |
Why?
|
| Dominican Republic | 2 | 2023 | 20 | 0.260 |
Why?
|
| Immune System | 2 | 2020 | 41 | 0.260 |
Why?
|
| Serologic Tests | 2 | 2022 | 43 | 0.250 |
Why?
|
| Child, Preschool | 7 | 2024 | 1418 | 0.240 |
Why?
|
| Genomics | 2 | 2023 | 223 | 0.240 |
Why?
|
| Sentinel Surveillance | 1 | 2024 | 21 | 0.240 |
Why?
|
| Adolescent | 8 | 2024 | 5363 | 0.240 |
Why?
|
| Culicidae | 1 | 2023 | 24 | 0.230 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2022 | 448 | 0.230 |
Why?
|
| Child Development | 1 | 2024 | 88 | 0.220 |
Why?
|
| Leukopenia | 1 | 2022 | 9 | 0.220 |
Why?
|
| Thrombocytopenia | 1 | 2022 | 21 | 0.220 |
Why?
|
| Faculty | 1 | 2023 | 94 | 0.220 |
Why?
|
| Bayes Theorem | 1 | 2023 | 94 | 0.220 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2024 | 162 | 0.210 |
Why?
|
| Social Environment | 1 | 2024 | 207 | 0.210 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2022 | 8 | 0.210 |
Why?
|
| Microcephaly | 1 | 2022 | 19 | 0.210 |
Why?
|
| Wolbachia | 1 | 2021 | 2 | 0.210 |
Why?
|
| Peru | 1 | 2021 | 30 | 0.200 |
Why?
|
| Astrocytes | 3 | 2013 | 255 | 0.200 |
Why?
|
| Cyclonic Storms | 1 | 2023 | 64 | 0.200 |
Why?
|
| Viruses | 1 | 2022 | 36 | 0.200 |
Why?
|
| Molecular Sequence Data | 4 | 2009 | 1568 | 0.200 |
Why?
|
| Bile Acids and Salts | 1 | 2001 | 33 | 0.190 |
Why?
|
| Molecular Epidemiology | 2 | 2018 | 50 | 0.190 |
Why?
|
| Perception | 1 | 2022 | 195 | 0.190 |
Why?
|
| Pyridones | 1 | 2021 | 40 | 0.190 |
Why?
|
| Health Personnel | 1 | 2023 | 228 | 0.190 |
Why?
|
| Laboratories | 1 | 2020 | 35 | 0.180 |
Why?
|
| Aged | 6 | 2024 | 6741 | 0.180 |
Why?
|
| Infant | 4 | 2024 | 1046 | 0.170 |
Why?
|
| Community Health Services | 1 | 2020 | 185 | 0.170 |
Why?
|
| Alcohol-Related Disorders | 1 | 2020 | 55 | 0.170 |
Why?
|
| Seroepidemiologic Studies | 3 | 2023 | 68 | 0.170 |
Why?
|
| Mouth | 1 | 2018 | 45 | 0.160 |
Why?
|
| Bacterial Proteins | 3 | 2004 | 540 | 0.160 |
Why?
|
| Risk-Taking | 1 | 2021 | 451 | 0.160 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 171 | 0.160 |
Why?
|
| Prevalence | 2 | 2023 | 1455 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 234 | 0.140 |
Why?
|
| Sexual Behavior | 1 | 2021 | 609 | 0.140 |
Why?
|
| Cytokines | 1 | 2018 | 602 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2009 | 1371 | 0.120 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 7 | 0.120 |
Why?
|
| Chemokine CCL5 | 1 | 2013 | 39 | 0.120 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 93 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1015 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2013 | 325 | 0.110 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 51 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2379 | 0.100 |
Why?
|
| Memory Disorders | 1 | 2012 | 73 | 0.100 |
Why?
|
| Cross Reactions | 2 | 2022 | 83 | 0.100 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2011 | 55 | 0.100 |
Why?
|
| Vaccination | 2 | 2023 | 288 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2011 | 153 | 0.090 |
Why?
|
| Sequence Alignment | 2 | 2009 | 265 | 0.090 |
Why?
|
| Genes, env | 1 | 2009 | 13 | 0.090 |
Why?
|
| Genes, Regulator | 1 | 2009 | 25 | 0.090 |
Why?
|
| Brain Chemistry | 1 | 2009 | 140 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 409 | 0.080 |
Why?
|
| Hippocampus | 1 | 2012 | 561 | 0.080 |
Why?
|
| Narcotics | 1 | 2008 | 32 | 0.080 |
Why?
|
| Primates | 1 | 2008 | 36 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2011 | 339 | 0.080 |
Why?
|
| HIV Reverse Transcriptase | 2 | 2020 | 33 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 191 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 1180 | 0.080 |
Why?
|
| Pregnancy | 2 | 2024 | 1549 | 0.080 |
Why?
|
| Oxidants | 1 | 2007 | 45 | 0.080 |
Why?
|
| Phenotype | 1 | 2009 | 689 | 0.070 |
Why?
|
| HIV | 1 | 2007 | 98 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2012 | 1518 | 0.060 |
Why?
|
| Antigens, Viral | 1 | 2024 | 43 | 0.060 |
Why?
|
| Flagella | 1 | 2004 | 29 | 0.060 |
Why?
|
| Antioxidants | 1 | 2007 | 416 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 55 | 0.060 |
Why?
|
| Vaccines, Attenuated | 1 | 2023 | 72 | 0.060 |
Why?
|
| Dyspnea | 1 | 2022 | 18 | 0.050 |
Why?
|
| Cough | 1 | 2022 | 18 | 0.050 |
Why?
|
| Neurologic Examination | 1 | 2022 | 30 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 61 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2023 | 106 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 109 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2022 | 109 | 0.050 |
Why?
|
| Communication | 1 | 2023 | 180 | 0.050 |
Why?
|
| United States | 2 | 2022 | 4223 | 0.050 |
Why?
|
| Endemic Diseases | 1 | 2021 | 20 | 0.050 |
Why?
|
| Transfection | 2 | 2013 | 523 | 0.050 |
Why?
|
| Enteritis | 1 | 2001 | 4 | 0.050 |
Why?
|
| Campylobacter Infections | 1 | 2001 | 7 | 0.050 |
Why?
|
| Sexual Behavior, Animal | 1 | 2021 | 53 | 0.050 |
Why?
|
| Intention | 1 | 2022 | 94 | 0.050 |
Why?
|
| Chloramphenicol | 1 | 2001 | 5 | 0.050 |
Why?
|
| Deoxycholic Acid | 1 | 2001 | 10 | 0.050 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2021 | 45 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2007 | 938 | 0.050 |
Why?
|
| Cell Line | 3 | 2013 | 1354 | 0.050 |
Why?
|
| Eukaryotic Cells | 1 | 2001 | 36 | 0.050 |
Why?
|
| Bacterial Adhesion | 1 | 2001 | 37 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 155 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 208 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2020 | 40 | 0.050 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2001 | 149 | 0.050 |
Why?
|
| Base Sequence | 1 | 2022 | 997 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2013 | 1908 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2019 | 26 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 935 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2022 | 894 | 0.040 |
Why?
|
| Parents | 1 | 2022 | 329 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 1999 | 90 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 217 | 0.040 |
Why?
|
| Culture Media | 1 | 1999 | 90 | 0.040 |
Why?
|
| Serum Albumin, Bovine | 1 | 1999 | 51 | 0.040 |
Why?
|
| Phagocytosis | 1 | 1999 | 69 | 0.040 |
Why?
|
| Age Factors | 1 | 2021 | 1033 | 0.040 |
Why?
|
| Hospitalization | 1 | 2021 | 388 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 898 | 0.040 |
Why?
|
| Students | 1 | 2023 | 519 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 400 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1369 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 922 | 0.040 |
Why?
|
| Cattle | 1 | 1999 | 477 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2020 | 2026 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 3562 | 0.030 |
Why?
|
| Brain Tissue Transplantation | 1 | 2012 | 3 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 623 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 208 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 85 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2011 | 41 | 0.020 |
Why?
|
| Fetus | 1 | 2011 | 105 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 893 | 0.020 |
Why?
|
| Motor Activity | 1 | 2012 | 418 | 0.020 |
Why?
|
| Macrophages | 1 | 2012 | 439 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 1999 | 325 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1207 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2007 | 41 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 1618 | 0.020 |
Why?
|
| Catalase | 1 | 2007 | 109 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2007 | 189 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 155 | 0.020 |
Why?
|
| Viral Load | 1 | 2007 | 312 | 0.020 |
Why?
|
| Anxiety | 1 | 2012 | 754 | 0.020 |
Why?
|
| Neurons | 1 | 2012 | 1175 | 0.020 |
Why?
|
| Proton-Translocating ATPases | 1 | 2004 | 16 | 0.020 |
Why?
|
| Sigma Factor | 1 | 2004 | 19 | 0.020 |
Why?
|
| Virulence | 1 | 2004 | 223 | 0.010 |
Why?
|
| Foodborne Diseases | 1 | 2001 | 22 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2001 | 122 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1999 | 46 | 0.010 |
Why?
|
| Gene Library | 1 | 1999 | 57 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1999 | 101 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 283 | 0.010 |
Why?
|
| Plasmids | 1 | 1999 | 246 | 0.010 |
Why?
|
| Models, Biological | 1 | 2001 | 677 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 515 | 0.010 |
Why?
|